Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 3, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Molecular Testing Products
4.00K
Molecular Testing Products Growth
-98.69%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States
4.00K
United States Growth
-98.69%